Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARCS 2: Personalized Dosing of Rekovelle and Menopur in IVF
NCT06997900Phase 2Recruiting
- Sponsor
- clinique ovo
- Start
- Jul 2025
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of follitropin delta in infertility, sponsored by clinique ovo. Started Jul 2025; status: recruiting.
02
Drugs
follitropin delta
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06997900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06997900.